Sanofi (Group) [since May 2011]

https://www.sanofi.com

Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

	Start	2011-05-06 renamed
	Predecessor	Sanofi-Aventis (Group)
	Industry	pharmaceutical

	Region	Paris
	Country	France
	Street	174 avenue de France
	City	75635 Paris
	Tel	+33-1-5377-4000
		Address record changed: 2020-12-02

Basic data	Employees	I: 50,001 to 100,0 (2021-12-31)
	Currency	EUR
	Annual sales	37,761,000,000 (sales, net, consolidated (2021) 2021-12-31)
	Profit	6,279,000,000 (2021-12-31)
	Cash	10,098,000,000 (2021-12-31)

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Sanofi (Group) [since May 2011]

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top